<DOC>
	<DOCNO>NCT02928289</DOCNO>
	<brief_summary>The purpose study evaluate safety effectiveness Sight Sciences VISCO™360 Viscosurgical System reduce intraocular pressure ( IOP ) adult , pseudophakic subject open-angle glaucoma .</brief_summary>
	<brief_title>Randomized Study Safety Effectiveness Sight Sciences VISCO™360 Viscosurgical System Versus SLT Primary Open Angle Glaucoma ( VISCO360 Study )</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<criteria>Diagnosed primary openangle glaucoma ( POAG ) study eye . Pseudophakic Posterior Chamber IOL ( PCIOL ) Able willing attend follow visit two year postoperative Able willing sign inform consent Phakia aphakia Previous glaucoma procedure without implantable glaucoma device ( include incisional surgery , ALT , iridectomy/iridotomy , etc . ) [ Subjects one prior SLT application ( &gt; 3 month prior screen ) prior ECP ( perform &gt; 12 month prior screen ) enrol ] . Use 3 ocular hypotensive medication ( combination medication count 2 medication ) Diagnosis acute angle closure , traumatic , congenital , malignant , uveitic , pseudoexfoliative , pigmentary neovascular glaucoma Abnormal angle anatomy determine gonioscopy ( e.g . peripheral anterior synechiae , rubeosis angle abnormality ) Participation clinical trial ≤ 30 day prior screen</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>